Claybrook Capital’s Inogen INGN Stock Holding History

Claybrook Capital’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-42	Closed	-$5K	–	374
2018 Q4	$5K	Buy	+42	New	+$6.92K	﹤0.01%	573

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Claybrook Capital's INGN Position: Q1 2019 in Review

Claybrook Capital sold out of Inogen (INGN) in Q1 2019, closing a stake of 42 shares — an estimated $5K sold.

Claybrook Capital first reported a position in INGN in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

Claybrook Capital reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 42 Inogen shares in Q1 2019, an estimated $5K.
Claybrook Capital first reported a position in Inogen in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Inogen position peaked at $5K in Q4 2018.
239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.